Terms: = Ovarian cancer AND FOXL2, BPES, 668, ENSG00000183770, P58012, PFRK, POF3, PINTO, BPES1 AND Treatment
43 results:
1. Evaluating the Prognostic Factors and Survival Rates of Endometrial cancer Patients in a Tertiary Referral Hospital in Northeast Thailand.
Wannasin R; Thinkhamrop K; Kelly M; Likitdee N
Asian Pac J Cancer Prev; 2024 Feb; 25(2):671-679. PubMed ID: 38415555
[TBL] [Abstract] [Full Text] [Related]
2. Review on Sertoli-Leydig Cell Tumours of the Ovary.
Muscat C; Calleja-Agius J
Discov Med; 2024 Feb; 36(181):234-247. PubMed ID: 38409829
[TBL] [Abstract] [Full Text] [Related]
3. Morphological Changes of the ovarian Vein in Pelvic Venous Disorders.
Nykonenko A; Trailin A; Lazarashvili Z; Proczka RM; Havrylenko B; Nykonenko O
Eur J Vasc Endovasc Surg; 2024 Mar; 67(3):500-505. PubMed ID: 37952635
[TBL] [Abstract] [Full Text] [Related]
4. The cost-effectiveness analysis of maintenance olaparib plus Bevacizumab in patients with advanced ovarian cancer: based on the final survival results from PAOLA-1 trial.
Zhu Y; Liu K; Cao H; Zhu H
J Ovarian Res; 2023 Aug; 16(1):168. PubMed ID: 37605274
[TBL] [Abstract] [Full Text] [Related]
5. Adult granulosa cell tumor of the testis with malignant tendency: A case report with genetic analysis using high-throughput sequencing.
Deng L; Zeng J; Qiu JF; Yang LH; Ma J
Medicine (Baltimore); 2023 Aug; 102(32):e34523. PubMed ID: 37565864
[TBL] [Abstract] [Full Text] [Related]
6. ovarian epithelioid malignant peripheral nerve sheath tumor with EWSR1-CREM fusion: A case report and literature review.
Li S; Hong R; Wang X; Yang J
Int J Gynaecol Obstet; 2023 Nov; 163(2):521-527. PubMed ID: 37151162
[TBL] [Abstract] [Full Text] [Related]
7. foxl2 in adult-type granulosa cell tumour of the ovary: oncogene or tumour suppressor gene?
Pilsworth JA; Todeschini AL; Neilson SJ; Cochrane DR; Lai D; Anttonen M; Heikinheimo M; Huntsman DG; Veitia RA
J Pathol; 2021 Nov; 255(3):225-231. PubMed ID: 34338304
[TBL] [Abstract] [Full Text] [Related]
8. Prevalence of predictive biomarkers in a large cohort of molecularly defined adult-type ovarian granulosa cell tumors.
Hillman RT; Lin DI; Lawson B; Gershenson DM
Gynecol Oncol; 2021 Sep; 162(3):728-734. PubMed ID: 34238613
[TBL] [Abstract] [Full Text] [Related]
9. foxl2 and TERT promoter mutation detection in circulating tumor DNA of adult granulosa cell tumors as biomarker for disease monitoring.
Groeneweg JW; Roze JF; Peters EDJ; Sereno F; Brink AGJ; Paijens ST; Nijman HW; van Meurs HS; van Lonkhuijzen LRCW; Piek JMJ; Lok CAR; Monroe GR; van Haaften GW; Zweemer RP
Gynecol Oncol; 2021 Aug; 162(2):413-420. PubMed ID: 34083028
[TBL] [Abstract] [Full Text] [Related]
10. Pharmacokinetics and safety of rucaparib in patients with advanced solid tumors and hepatic impairment.
Grechko N; Skarbova V; Tomaszewska-Kiecana M; Ramlau R; Centkowski P; Drew Y; Dziadziuszko R; Zemanova M; Beltman J; Nash E; Habeck J; Liao M; Xiao J
Cancer Chemother Pharmacol; 2021 Aug; 88(2):259-270. PubMed ID: 33909097
[TBL] [Abstract] [Full Text] [Related]
11. FOXO1 mitigates the SMAD3/foxl2
Secchi C; Benaglio P; Mulas F; Belli M; Stupack D; Shimasaki S
J Transl Med; 2021 Feb; 19(1):90. PubMed ID: 33639972
[TBL] [Abstract] [Full Text] [Related]
12. Patient cost sharing during poly(adenosine diphosphate-ribose) polymerase inhibitor treatment in ovarian cancer.
Harrison RF; Fu S; Sun CC; Zhao H; Lu KH; Giordano SH; Meyer LA
Am J Obstet Gynecol; 2021 Jul; 225(1):68.e1-68.e11. PubMed ID: 33549538
[TBL] [Abstract] [Full Text] [Related]
13. ovarian granulosa cell tumor characterization identifies foxl2 as an immunotherapeutic target.
Pierini S; Tanyi JL; Simpkins F; George E; Uribe-Herranz M; Drapkin R; Burger R; Morgan MA; Facciabene A
JCI Insight; 2020 Aug; 5(16):. PubMed ID: 32814714
[TBL] [Abstract] [Full Text] [Related]
14. Potentially functional variants in nucleotide excision repair pathway genes predict platinum treatment response of Chinese ovarian cancer patients.
Li H; Dai H; Shi T; Cheng X; Sun M; Chen K; Wang M; Wei Q
Carcinogenesis; 2020 Sep; 41(9):1229-1237. PubMed ID: 32663249
[TBL] [Abstract] [Full Text] [Related]
15. The PARP inhibitor, olaparib, depletes the ovarian reserve in mice: implications for fertility preservation.
Winship AL; Griffiths M; Lliberos Requesens C; Sarma U; Phillips KA; Hutt KJ
Hum Reprod; 2020 Aug; 35(8):1864-1874. PubMed ID: 32604417
[TBL] [Abstract] [Full Text] [Related]
16. Androgen-Secreting ovarian Tumors.
Macut D; Ilić D; Mitrović Jovanović A; Bjekić-Macut J
Front Horm Res; 2019; 53():100-107. PubMed ID: 31499493
[TBL] [Abstract] [Full Text] [Related]
17. Timely expression and activation of YAP1 in granulosa cells is essential for ovarian follicle development.
Lv X; He C; Huang C; Wang H; Hua G; Wang Z; Zhou J; Chen X; Ma B; Timm BK; Maclin V; Dong J; Rueda BR; Davis JS; Wang C
FASEB J; 2019 Sep; 33(9):10049-10064. PubMed ID: 31199671
[TBL] [Abstract] [Full Text] [Related]
18. Time to chemotherapy in ovarian cancer: Compliance with ovarian cancer quality indicators at a National cancer Institute-designated Comprehensive cancer Center.
ElNaggar AC; Hade EM; O'Malley DM; Liang MI; Copeland LJ; Fowler JM; Salani R; Backes FJ; Cohn DE
Gynecol Oncol; 2018 Dec; 151(3):501-505. PubMed ID: 30282591
[TBL] [Abstract] [Full Text] [Related]
19. KMT2D/MLL2 inactivation is associated with recurrence in adult-type granulosa cell tumors of the ovary.
Hillman RT; Celestino J; Terranova C; Beird HC; Gumbs C; Little L; Nguyen T; Thornton R; Tippen S; Zhang J; Lu KH; Gershenson DM; Rai K; Broaddus RR; Futreal PA
Nat Commun; 2018 Jun; 9(1):2496. PubMed ID: 29950560
[TBL] [Abstract] [Full Text] [Related]
20. Distinct DNA Methylation Profiles in ovarian Tumors: Opportunities for Novel Biomarkers.
Losi L; Fonda S; Saponaro S; Chelbi ST; Lancellotti C; Gozzi G; Alberti L; Fabbiani L; Botticelli L; Benhattar J
Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29882921
[TBL] [Abstract] [Full Text] [Related]
[Next]
